Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05476523 · ClinicalTrials.gov registry record
Development and Validation of a Novel Eye-Tracking Software-based Platform to Extract Oculometric Measures
A clinical trial of Eye Movement, sponsored by NeuraLight.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT05476523 is a study of Eye Movement that is actively recruiting participants, run by NeuraLight. The registered enrollment target is 2,000 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05476523, a study of Eye Movement, is actively recruiting participants, sponsored by NeuraLight.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an observational prospective study in a cohort of healthy subjects who are enrolled using convenience and snowballing sampling. The aims of the study is to demonstrate the efficacy of using NeuraLight system to capture oculometric data from healthy participants and to validate the data capture of NeuraLight oculometric measurements as compared with a validated eye-tracker system in subjects who meet the inclusion criteria and who provide a signed Informed Consent.
Conditions Studied
Interventions
- OTHER NeuraLight
Study Locations (1)
Delaware
- NeuraLight - Wilmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2022-07-22 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05476523
The ClinicalTrials.gov registry entry for NCT05476523 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NeuraLight, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Eye Movement appearing as the primary indexed condition, and to 1 intervention - of which NeuraLight is the first listed.
NCT05476523 reports 1 study location spanning 1 distinct geographic area - top geographies include Delaware.
Frequently Asked Questions
What is clinical trial NCT05476523 about?
NCT05476523 is a clinical study titled "Development and Validation of a Novel Eye-Tracking Software-based Platform to Extract Oculometric Measures". This is an observational prospective study in a cohort of healthy subjects who are enrolled using convenience and snowballing sampling. The aims of the study is to demonstrate the efficacy of using NeuraLight system to capture oculometric data from healthy participants and to validate the data captu...
What is the current status of trial NCT05476523?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2022-07-22. Estimated completion is 2026-12-31.
What conditions does trial NCT05476523 study?
This clinical trial studies the following conditions: Eye Movement.
What interventions are being tested in trial NCT05476523?
The interventions under investigation include: NeuraLight (OTHER).
Who is sponsoring clinical trial NCT05476523?
This trial is sponsored by NeuraLight, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05476523 being conducted?
This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.